Meta Pixel

News and Announcements

DroneShield Ltd (ASX:DRO) RfPatrolTM achieves notified body compliance testing

  • Published August 20, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

DroneShield Ltd (ASX: DRO or DRO.AU) (“DroneShield”) is pleased to announce its passive (non-emitting) body-worn drone detector RfPatrolTM has achieved accredited notified body compliance testing to the European Commission Electromagnetic Compatibility Directive 2014/30/EU.

Along with compliance to the RoHS and applicable EN60950-1 Safety Directives as required for Article 30 of Regulation (EC) No 765/2008, the RfPatrolTM conforms to the requirements for CE marking for the product to be sold within the European Economic Area (EEA). The certification was obtained in response to DroneShield’s European partner and end-user feedback, as the product receives a high level of interest not only from military, but also civilian customers.

Image: RfPatrolTM in storage case

DroneShield’s CEO Oleg Vornik commented, “RfPatrolTM is expected to appeal to a wide range of users due to its portable size, cost-competitive pricing and passive nature. Non-military markets such as sports and public venues, commercial and VIP security and critical infrastructure are an important part of our business, and achieving the CE certification is an important part of European market adoption process. We believe this is the world’s first counter-drone product that has achieved CE compliance certification.”

For enquiries, please register your interest below.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now